# Precision System Science Co., Ltd.: business model and financials

> Latest period: FY ending Jun 2026, consolidated, J-GAAP
> Unit: JPY millions
> Sources: 有価証券報告書－第41期(2025/07/01－2026/06/30) (S100Z33F)
> Page: https://vizora.meequs.com/en/company/precision-system-science
> Retrieved: 2026-09-30T21:03:35.761Z

## Company

Precision System Science, founded in 1985, is a company in Medical Devices listed on TSE Growth. It has 129 employees (consolidated).

| Field | Value |
| --- | ---: |
| Legal name | Precision System Science Co., Ltd. |
| Ticker | 7707 |
| Stock price | View on Yahoo Finance (https://finance.yahoo.co.jp/quote/7707.T) |
| Listing | TSE Growth |
| Head office | 千葉県松戸市上本郷88番地 |
| Representative (per filing) | 代表取締役社長 杉山 悠 |
| Founded | Jul 1985 |
| Share capital | ¥100M |
| Employees (consolidated) | 129 |
| Average salary (parent only) | ¥5.5M |
| Fiscal year end | June |
| Website | www.pss.co.jp (https://www.pss.co.jp/) |
| Corporate number | 9040001037483 |
| EDINET | E02338 |
| Industries (Vizora) | Medical Devices |

> Profile source: annual securities report (S100Z33F, filed 2026-09-18). As of filing

## Five-axis industry profile

Primary industry: Medical Devices (2026-06-30)

| Axis | Industry percentile | Peers |
| --- | ---: | ---: |
| Revenue growth | 1.3 | 38 |
| Profitability | 16.7 | 39 |
| Cash conversion | 6.6 | 38 |
| Efficiency | 85.9 | 39 |

Each axis is shown independently. Missing values are labeled unavailable; no combined score is calculated. Industry rank is not an investment recommendation.

## Key points (generated from figures)

- Precision System Science brought in ¥5.22B in revenue.
- Out of every ¥100 of sales, about ¥4 is left as operating profit.
- Revenue changed +11.2% from the prior year, and it swung back to an operating profit.

## Company structure

- Segment revenue mix: Segment revenue breakdown is not disclosed
- Revenue → net income: ¥5216912000 → ¥394873000
- Net income → operating cash flow: ¥394873000 → ¥51409000（difference ¥-343464000）
- Main uses of operating cash flow: CapEx ¥102578000 / dividends — / buybacks ¥9000
- Change in cash: ¥446098000
Segment shares use total reported segment revenue, which may include inter-segment sales. The cash bridge is operating cash flow minus net income and combines non-cash items and working-capital effects.

## Key figures at a glance

| Metric | Value | Note |
| --- | ---: | ---: |
| Revenue | ¥5.22B |  |
| Operating income | ¥201.3M | Margin 3.9% |
| Net income | ¥394.9M | Margin 7.6% |
| Free cash flow | -¥51.2M |  |
| Employees (consolidated) | 129 |  |
| EPS | ¥22.25 |  |
| Book value per share | ¥145.74 |  |
| Equity ratio | 69.9% |  |
| Shares outstanding | 27,666,900 |  |
| Treasury shares | 206,100 |  |
| Shareholders | 14,358 |  |
| Average salary (parent only) | ¥5.5M | Filing company only |
| Cash ratio | 23.3% | Cash ÷ revenue 26.2% |
| Vs. industry median margin | -7.2 pp | Medical Devices |
| ROE | 10.1% | Derived from disclosed figures |
| ROA | 7.3% | Derived from disclosed figures |

## What changed in 5 years

| Metric | FY ending Jun 2021 | FY ending Jun 2026 | Change |
| --- | ---: | ---: | ---: |
| Revenue | ¥9298741000 | ¥5216912000 | -43.9% |
| Operating income | ¥895287000 | ¥201307000 | -77.5% |
| Operating margin | 9.6% | 3.9% | -5.8 pp |
| Employees | 187 people | 129 people | -31.0% |
| Cash and equivalents | ¥4019002000 | ¥1365967000 | -66.0% |

### Change in segment revenue mix

Span: FY ending Jun 2021 → FY ending Jun 2026. Stable segment keys are connected; unmatched shares are marked as new or reorganized. Shares use total segment revenue.

## Income statement（FY ending Jun 2026, consolidated, J-GAAP）

| Item | Amount (JPY mn) | % of revenue | Source |
| --- | ---: | ---: | ---: |
| Revenue | 5,217 | 100.0% | S100Z33F |
| Cost of revenue | 3,633 | 69.6% | S100Z33F |
| Gross profit | 1,584 | 30.4% | S100Z33F |
| SG&A | 1,383 | 26.5% | S100Z33F |
| Operating income | 201 | 3.9% | S100Z33F |
| Ordinary income | 156 | 3.0% | S100Z33F |
| Pretax income | 254 | 4.9% | S100Z33F |
| Income tax | -140 | -2.7% | S100Z33F |
| Net income | 395 | 7.6% | S100Z33F |
| Net income attributable to owners | 395 | 7.6% | S100Z33F |

## Per ¥100 of revenue（FY ending Jun 2026）

| Part | JPY |
| --- | ---: |
| Cost of revenue | 70 |
| SG&A | 26 |
| Operating income | 4 |
| (Ref.) Net income | 8 |

### Margin funnel

Gross margin 30.4% → Operating margin 3.9% → Net margin 7.6%
Derived from reported figures (DERIVED).

## Revenue and profit pattern

Pattern: Turned profitable
Calculated from comparable annual consolidated filings.

## Year over year（FY ending Jun 2025 → FY ending Jun 2026、JPY mn）

| Metric | Prior | Current | Change | % change |
| --- | ---: | ---: | ---: | ---: |
| Revenue | 4,693 | 5,217 | 524 | +11.2% |
| Gross profit | 1,381 | 1,584 | 203 | +14.7% |
| Operating income | -121 | 201 | 323 | — |
| Net income attributable to owners | -253 | 395 | 648 | — |
| Operating cash flow | 96 | 51 | -44 | -46.4% |
| Free cash flow | 43 | -51 | -94 | -219.7% |

## History（JPY mn）

| Period | Revenue | Op. income | Op. margin | Net income | Op. CF | FCF | Source |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| FY ending Jun 2020 | 5,067 | -82 | -1.6% | -114 | -21 | -252 | S100MIHV |
| FY ending Jun 2021 | 9,299 | 895 | 9.6% | 796 | -281 | -2,093 | S100P9Q5 |
| FY ending Jun 2022 | 7,434 | 152 | 2.0% | 45 | 869 | -1,380 | S100RY67 |
| FY ending Jun 2023 | 5,278 | -1,112 | -21.1% | -1,324 | -7 | -162 | S100UGNR |
| FY ending Jun 2024 | 3,980 | -956 | -24.0% | -1,121 | -107 | -131 | S100WS3N |
| FY ending Jun 2025 | 4,693 | -121 | -2.6% | -253 | 96 | 43 | S100Z33F |
| FY ending Jun 2026 | 5,217 | 201 | 3.9% | 395 | 51 | -51 | S100Z33F |

## People and productivity（FY ending Jun 2026, consolidated, J-GAAP）

| Metric | Value |
| --- | ---: |
| Revenue per employee (consolidated) | ¥40.4M |
| Operating income per employee (consolidated) | ¥1.6M |
| Net income per employee (consolidated) | ¥3.1M |

Employees, revenue and profit are consolidated. Average annual salary is a separate parent-company figure. Calculated from disclosed figures (DERIVED).

| History | FY ending Jun 2022 | FY ending Jun 2023 | FY ending Jun 2024 | FY ending Jun 2025 | FY ending Jun 2026 |
| --- | ---: | ---: | ---: | ---: | ---: |
| Employees (consolidated) | 196 | 199 | 158 | 151 | 129 |
| Average salary (parent company) | ¥6.1M | ¥5.5M | ¥5.5M | ¥6M | ¥5.5M |
| Average age (parent company) | 45.1 years | 44.1 years | 45.6 years | 46.5 years | 45.4 years |
| Average tenure (parent company) | 8.9 years | 8.2 years | 9.4 years | 9.3 years | 10.9 years |

Year over year: Employees (consolidated) -14.6% · Revenue (consolidated) +11.2%

## Revenue by geography

No geographic revenue breakdown was disclosed.

## Cash flow（FY ending Jun 2026, consolidated, J-GAAP）

| Item | Amount (JPY mn) | % of revenue | Source |
| --- | ---: | ---: | ---: |
| Operating cash flow | 51 | 1.0% | S100Z33F |
| Capital expenditure | 103 | 2.0% | S100Z33F |
| Free cash flow | -51 | -1.0% | 算出 |
| Investing cash flow | -98 | -1.9% | S100Z33F |
| Financing cash flow | 461 | 8.8% | S100Z33F |
| Share buyback | 0 | 0.0% | S100Z33F |
| Change in cash | 446 | 8.6% | S100Z33F |
| Cash and equivalents | 1,366 | 26.2% | S100Z33F |

## Balance sheet

Figures are as of each fiscal year end. Derived values are marked as such in the source column. Lease liabilities are excluded from interest-bearing debt.

| Metric | FY ending Jun 2022 | FY ending Jun 2023 | FY ending Jun 2024 | FY ending Jun 2025 | FY ending Jun 2026 | Source |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | 2,744 | 2,426 | 1,895 | 1,036 | 1,366 | S100UGNR, S100WS3N, S100Z33F |
| Total assets | 11,410 | 9,762 | 6,397 | 4,938 | 5,854 | S100RY67, S100UGNR, S100WS3N, S100Z33F |
| Net assets | 6,512 | 5,222 | 4,143 | 3,761 | 4,090 | S100UGNR, S100WS3N, S100Z33F |
| Share capital | 4,644 | 4,644 | 100 | 100 | 100 | S100RY67, S100UGNR, S100WS3N, S100Z33F |
| Property, plant and equipment | 3,831 | 3,374 | 1,581 | 1,444 | 1,342 | S100RY67, S100UGNR, S100WS3N, S100Z33F |
| Intangible assets excluding goodwill | 420 | 345 | 138 | 84 | 34 | S100RY67, S100UGNR, S100WS3N, S100Z33F |
| Investment securities | 37 | 81 | 55 | 34 | 34 | S100RY67, S100UGNR, S100WS3N, S100Z33F |
| Current assets | 6,990 | 5,872 | 4,610 | 3,367 | 4,087 | S100RY67, S100UGNR, S100WS3N, S100Z33F |
| Current liabilities | 2,218 | 2,006 | 1,959 | 1,146 | 1,465 | S100RY67, S100UGNR, S100WS3N, S100Z33F |
| Trade payables | 405 | 296 | 382 | 349 | 384 | S100RY67, S100UGNR, S100WS3N, S100Z33F |
| Short-term borrowings | 1,100 | 800 | 800 | 500 | 600 | S100RY67, S100UGNR, S100WS3N, S100Z33F |
| Long-term borrowings | 2,672 | 2,522 | 290 | 30 | 298 | S100RY67, S100UGNR, S100WS3N, S100Z33F |
| Total liabilities | 4,898 | 4,539 | 2,254 | 1,177 | 1,764 | S100RY67, S100UGNR, S100WS3N, S100Z33F |
| Equity attributable to owners of parent | 6,506 | 5,182 | 4,060 | 3,707 | 4,099 | S100RY67, S100UGNR, S100WS3N, S100Z33F |
| Retained earnings | 732 | -593 | -1,714 | -1,967 | 706 | S100RY67, S100UGNR, S100WS3N, S100Z33F |
| Treasury stock | -23 | -23 | -23 | -124 | -54 | S100RY67, S100UGNR, S100WS3N, S100Z33F |

### Assets and funding mix

| Assets | Share | Source |
| --- | ---: | ---: |
| Cash | 23% | S100Z33F |
| Property, plant and equipment | 23% | S100Z33F |
| Intangibles and goodwill | 1% | S100Z33F |
| Investment securities | 1% | S100Z33F |
| Other assets | 52% | S100Z33F |

| Funding source | Share | Source |
| --- | ---: | ---: |
| Trade payables | 6% | S100Z33F |
| Other liabilities | 24% | S100Z33F |
| Equity | 70% | S100Z33F |
| Other liabilities | 0% | S100Z33F |

### Balance sheet history

| Metric | FY ending Jun 2022 | FY ending Jun 2023 | FY ending Jun 2024 | FY ending Jun 2025 | FY ending Jun 2026 |
| --- | ---: | ---: | ---: | ---: | ---: |
| Total assets | 11,410 | 9,762 | 6,397 | 4,938 | 5,854 |
| Equity | 6,512 | 5,222 | 4,143 | 3,761 | 4,090 |
| Interest-bearing debt | — | — | — | — | — |
| Cash | 2,744 | 2,426 | 1,895 | 1,036 | 1,366 |

## Asset intensity and goodwill

Ratios are derived from reported values. Goodwill is used only when separately reported, never inferred from combined intangible assets.

| Metric | Value | Sources |
| --- | ---: | ---: |
| Asset intensity (fixed assets ÷ revenue) | 25.7% | S100Z33F |
| Fixed assets ÷ total assets | 22.9% | S100Z33F |
| Goodwill ÷ parent equity | — | —, S100Z33F |

### Cash quality

Net cash = cash − interest-bearing debt. Net debt ratio = (interest-bearing debt − cash) ÷ positive operating cash flow. Omit when debt components are incomplete; other ratios are derived from reported figures.

| Metric | Value |
| --- | ---: |
| Cash ratio (cash ÷ total assets) | 23.3% |
| Cash ÷ revenue | 26.2% |
| Net cash (cash − interest-bearing debt) | — |
| Net debt ÷ operating cash flow | — |
| Cash conversion (operating CF ÷ operating income) | 25.5% |
| Cash vs. profit gap | -343 JPY mn (of net income -87.0%) |
| Shareholder returns / net income | — |
| Shareholder returns / FCF | — |
| Shareholder payments — dividends / net income | — |
| Shareholder payments — dividends / FCF | — |
| CapEx intensity (capex ÷ revenue) | 2.0% |
| Investing CF relative to operating CF | 190.7% |

## ROA and ROE

ROE is decomposed into net margin × asset turnover × financial leverage. Leverage can raise ROE, so the ratio alone does not assess a company's condition. Ending balances are used without a prior year; total equity approximates parent equity when unavailable.

| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE | Sources |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| 2022 | 0.6% | 0.65× | 0.4% | 1.75× | 0.7% | S100RY67 |
| 2023 | — | —× | -12.5% | —× | — | S100UGNR |
| 2024 | — | —× | -13.9% | —× | — | S100WS3N |
| 2025 | — | —× | -4.5% | —× | — | S100Z33F |
| 2026 | 7.6% | 0.97× | 7.3% | 1.38× | 10.1% | S100Z33F |

## Ownership

| Counterparty | Relation | Ratio | As of |
| --- | ---: | ---: | ---: |
| 田島 秀二 | Major shareholder | 16.8% | 2026-06-30 |
| 有限会社ユニテック | Major shareholder | 4.4% | 2026-06-30 |
| 株式会社ＳＢＩ証券 | Major shareholder | 3.0% | 2026-06-30 |
| 清板 大亮 | Major shareholder | 2.4% | 2026-06-30 |
| 楽天証券株式会社 | Major shareholder | 1.4% | 2026-06-30 |
| 新井 渉 | Major shareholder | 1.3% | 2026-06-30 |
| 小玉 博之 | Major shareholder | 0.5% | 2026-06-30 |
| 伊藤 健太 | Major shareholder | 0.5% | 2026-06-30 |
| 高橋 茂 | Major shareholder | 0.5% | 2026-06-30 |
| ＮＯＭＵＲＡ ＩＮＴＥＲＮＡＴＩＯＮＡＬ ＰＬＣ Ａ／Ｃ ＪＡＰＡＮ ＦＬＯＷ(常任代理人)野村證券株式会社 | Major shareholder | 0.5% | 2026-06-30 |

## Sources

| Document | ID | Published | URL |
| --- | ---: | ---: | ---: |
| 有価証券報告書－第41期(2025/07/01－2026/06/30) | S100Z33F | 2026-09-18 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100Z33F,, |
| 有価証券報告書－第40期(2024/07/01－2025/06/30) | S100WS3N | 2025-09-29 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100WS3N,, |
| 有価証券報告書－第39期(2023/07/01－2024/06/30) | S100UGNR | 2024-09-30 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100UGNR,, |
| 有価証券報告書－第38期(2022/07/01－2023/06/30) | S100RY67 | 2023-09-29 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100RY67,, |
| 有価証券報告書－第37期(令和3年7月1日－令和4年6月30日) | S100P9Q5 | 2022-09-30 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100P9Q5,, |
| 有価証券報告書－第36期(令和2年7月1日－令和3年6月30日) | S100MIHV | 2021-09-29 | https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100MIHV,, |

## Definitions

- Amounts are in millions of JPY (rounded). The period is stated in each table heading
- Operating margin = operating income ÷ revenue. Net income is attributable to owners of the parent when disclosed
- Free cash flow (FCF) = operating cash flow − capital expenditure
- ¥100 model = breakdown per ¥100 of revenue (rounded so parts sum to 100)
- Segment revenues include inter-segment sales and may not sum to consolidated revenue
- Source IDs are EDINET document IDs (docID). "算出" (derived) means computed from other disclosed values
- All figures are extracted mechanically from filings. AI-written text never generates figures
- Source: company filings submitted to EDINET (Financial Services Agency of Japan). Figures were extracted, edited and processed, and charts and text were created, by Vizora — not by the FSA (used under the Public Data License v1.0).